CLINICAL TRIALS PROFILE FOR OXTELLAR XR
✉ Email this page to a colleague
All Clinical Trials for OXTELLAR XR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00772603 ↗ | Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures | Completed | Parexel | Phase 3 | 2008-11-01 | Evaluation of the safety and efficacy of Oxcarbazepine XR as adjunctive treatment for adults with partial onset seizures |
NCT00772603 ↗ | Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures | Completed | Supernus Pharmaceuticals, Inc. | Phase 3 | 2008-11-01 | Evaluation of the safety and efficacy of Oxcarbazepine XR as adjunctive treatment for adults with partial onset seizures |
NCT03374709 ↗ | Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia | Withdrawn | University of Colorado, Denver | Phase 4 | 2018-12-14 | To evaluate the affect Oxtellar XR (Extended Release) has on neurology patients with trigeminal neuralgia (TN), and if it impacts their quality of life. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OXTELLAR XR
Condition Name
Clinical Trial Locations for OXTELLAR XR
Trials by Country
Clinical Trial Progress for OXTELLAR XR
Clinical Trial Phase
Clinical Trial Sponsors for OXTELLAR XR
Sponsor Name